Bottom line
LYFCX vs FTXH: the short answer
LYFCX (AlphaCentric Life Sciences and Healthcare Fund) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both mutual funds.
FTXH is cheaper at 0.6% vs 2.41% — a difference of $181 a year per $10,000 invested.
Over five years, FTXH returned +6.5% a year vs +4.6% for LYFCX.
Updated Nov 19, 2026
LYFCX vs FTXH side by side
| LYFCX | FTXH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Mutual | First Trust |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.41% | 0.6% |
| Annual cost per $10k | $241 | $60 |
| 10-yr cost on $10k (prospectus) | $3,346 | — |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +27.0% | +24.0% |
| 5-yr return (annualized) | +4.6% | +6.5% |
| 10-yr return (annualized) | — | — |
| Best quarter | +27.5% | +18.3% |
| Worst quarter | −11.9% | −17.4% |
| Net assets (fund) | $46.6M | $36.2M |
| Number of holdings | 62 | 51 |
| Portfolio turnover | 107% | 35% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
8 of LYFCX's top 25 holdings also appear in FTXH's top 25.
| Holding | LYFCX | FTXH |
|---|---|---|
| Gilead Sciences Inc | 5.53% | 2.89% |
| Vertex Pharmaceuticals Inc | 5.33% | 3.41% |
| Neurocrine Biosciences Inc | 3.51% | 1.37% |
| Incyte Corp | 3.51% | 2.39% |
| Abbvie Inc | 1.95% | 7.39% |
| Amgen Inc | 1.83% | 3.18% |
| Biogen Inc | 1.80% | 3.84% |
| Halozyme Therapeutics Inc | 1.58% | 1.21% |
Source: SEC Form N-PORT
LYFCX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
FAQ
What is the difference between LYFCX and FTXH?
LYFCX (AlphaCentric Life Sciences and Healthcare Fund) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both mutual funds. FTXH is cheaper at 0.6% vs 2.41% — a difference of $181 a year per $10,000 invested.
Which is cheaper, LYFCX or FTXH?
FTXH has the lower expense ratio (0.6%).
Should I own both LYFCX and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.